Paying users zone. Data is covered by hidden.

  • Get to Allergan PLC for $15.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Profitability Analysis

Difficulty: Beginner


Ratios (Summary)

Allergan PLC, profitability ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Return on Sales
Gross profit margin hidden% hidden% hidden% hidden% hidden%
Operating profit margin hidden% hidden% hidden% hidden% hidden%
Net profit margin hidden% hidden% hidden% hidden% hidden%
Return on Investment
Return on equity (ROE) hidden% hidden% hidden% hidden% hidden%
Return on assets (ROA) hidden% hidden% hidden% hidden% hidden%

Source: Based on data from Allergan PLC Annual Reports

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Allergan PLC's gross profit margin improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Allergan PLC's operating profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Allergan PLC's net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
ROE A profitability ratio calculated as net income divided by shareholders' equity. Allergan PLC's ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
ROA A profitability ratio calculated as net income divided by total assets. Allergan PLC's ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Gross Profit Margin

Allergan PLC, gross profit margin calculation

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Gross profit hidden hidden hidden hidden hidden
Net revenues hidden hidden hidden hidden hidden
Ratio
Gross profit margin1 hidden% hidden% hidden% hidden% hidden%
Benchmarks
Gross Profit Margin, Competitors
Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
Amgen Inc. hidden% hidden% hidden% hidden% hidden%
Biogen Inc. hidden% hidden% hidden% hidden% hidden%
Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
Celgene Corp. hidden% hidden% hidden% hidden% hidden%
Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%

Source: Based on data from Allergan PLC Annual Reports

2017 Calculations

1 Gross profit margin = 100 × Gross profit ÷ Net revenues
= 100 × hidden ÷ hidden = hidden%

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Allergan PLC's gross profit margin improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.

Operating Profit Margin

Allergan PLC, operating profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Operating loss hidden hidden hidden hidden hidden
Net revenues hidden hidden hidden hidden hidden
Ratio
Operating profit margin1 hidden% hidden% hidden% hidden% hidden%
Benchmarks
Operating Profit Margin, Competitors
Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
Amgen Inc. hidden% hidden% hidden% hidden% hidden%
Biogen Inc. hidden% hidden% hidden% hidden% hidden%
Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
Celgene Corp. hidden% hidden% hidden% hidden% hidden%
Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
Operating Profit Margin, Sector
Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
Operating Profit Margin, Industry
Health Care hidden% hidden% hidden% hidden% hidden%

Source: Based on data from Allergan PLC Annual Reports

2017 Calculations

1 Operating profit margin = 100 × Operating loss ÷ Net revenues
= 100 × hidden ÷ hidden = hidden%

Ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Allergan PLC's operating profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Net Profit Margin

Allergan PLC, net profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
Net revenues hidden hidden hidden hidden hidden
Ratio
Net profit margin1 hidden% hidden% hidden% hidden% hidden%
Benchmarks
Net Profit Margin, Competitors
Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
Amgen Inc. hidden% hidden% hidden% hidden% hidden%
Biogen Inc. hidden% hidden% hidden% hidden% hidden%
Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
Celgene Corp. hidden% hidden% hidden% hidden% hidden%
Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
Net Profit Margin, Sector
Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
Net Profit Margin, Industry
Health Care hidden% hidden% hidden% hidden% hidden%

Source: Based on data from Allergan PLC Annual Reports

2017 Calculations

1 Net profit margin = 100 × Net income (loss) attributable to shareholders ÷ Net revenues
= 100 × hidden ÷ hidden = hidden%

Ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Allergan PLC's net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Return on Equity (ROE)

Allergan PLC, ROE calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
Shareholders' equity hidden hidden hidden hidden hidden
Ratio
ROE1 hidden% hidden% hidden% hidden% hidden%
Benchmarks
ROE, Competitors
Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
Amgen Inc. hidden% hidden% hidden% hidden% hidden%
Biogen Inc. hidden% hidden% hidden% hidden% hidden%
Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
Celgene Corp. hidden% hidden% hidden% hidden% hidden%
Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
ROE, Sector
Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
ROE, Industry
Health Care hidden% hidden% hidden% hidden% hidden%

Source: Based on data from Allergan PLC Annual Reports

2017 Calculations

1 ROE = 100 × Net income (loss) attributable to shareholders ÷ Shareholders' equity
= 100 × hidden ÷ hidden = hidden%

Ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders' equity. Allergan PLC's ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Return on Assets (ROA)

Allergan PLC, ROA calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Ratio
ROA1 hidden% hidden% hidden% hidden% hidden%
Benchmarks
ROA, Competitors
Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
Amgen Inc. hidden% hidden% hidden% hidden% hidden%
Biogen Inc. hidden% hidden% hidden% hidden% hidden%
Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
Celgene Corp. hidden% hidden% hidden% hidden% hidden%
Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
ROA, Sector
Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
ROA, Industry
Health Care hidden% hidden% hidden% hidden% hidden%

Source: Based on data from Allergan PLC Annual Reports

2017 Calculations

1 ROA = 100 × Net income (loss) attributable to shareholders ÷ Total assets
= 100 × hidden ÷ hidden = hidden%

Ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Allergan PLC's ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.